Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

IMRN
Immuron Limited
stock NASDAQ ADR

Market Open
Sep 4, 2026 3:19:49 PM EDT
1.75USD0.000%(+1.75)115,152,450
1.74Bid   1.75Ask   0.01Spread
Pre-market
Sep 4, 2026 9:29:56 AM EDT
1.81USD+0.917%(+1.81)5,245,487
After-hours
Aug 31, 2026 4:00:30 PM EDT
1.11USD0.000%(+1.11)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 17, 2022
10:37AM EST  Immuron Received AUD $306,154 R&D Tax Concession Refund for 2021 Financial Year   Benzinga
06:00AM EST  Immuron Receives AUD $306,154 R&D Tax Concession Refund   GlobeNewswire Inc
Jan 13, 2022
11:43AM EST  Immuron Announced Receipt European Patent on Drug Composition to Treat Travelers' Diarrhea   Benzinga
06:00AM EST  Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, is pleased to announce that it has been granted a European Patent for compositions and methods for treating travelers diarrhea.   GlobeNewswire Inc
Jan 12, 2022
02:57PM EST  Mid-Afternoon Market Update: Nasdaq Rises 50 Points; Jefferies Shares Drop   Benzinga
12:32PM EST  Mid-Day Market Update: Crude Oil Rises 2%; Philips Shares Plummet   Benzinga
11:02AM EST  Immuron Ltd. (IMRN) shares are soaring more than 39 percent on Wednesday morning after the Australian biopharma company received funding of $4.45 million from the U.S. Department of Defense.   RTTNews
10:30AM EST  Mid-Morning Market Update: Markets Open Higher; US Inflation Rate Rises To 7% In December   Benzinga
08:30AM EST  The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award   Benzinga
06:00AM EST  Immuron Receives A$6.2 Million Award from U.S. DoD to Clinically   GlobeNewswire Inc
05:22AM EST  Immuron Awarded AU $6.2M to Clinically Evaluate a Military Strength Dosing Regimen for Travelan   Benzinga
Jan 5, 2022
01:23PM EST  Immuron Granted European Patent Titled 'COMPOSITION AND METHOD FOR THE TREATMENT AND PREVENTION OF ENTERIC BACTERIAL INFECTIONS'   Benzinga
Nov 15, 2021
10:41AM EST  Immuron Announced US DoD Uniformed Services University Travelers' Diarrhea Clinical Update   Benzinga
06:00AM EST  US DoD Uniformed Services University Travelers   GlobeNewswire Inc
Nov 10, 2021
06:00AM EST  US DoD Naval Medical Research Center Clinical Update   GlobeNewswire Inc
Oct 8, 2021
06:00AM EDT  IMM-124E Demonstrates Antiviral T-Cell Immunity   GlobeNewswire Inc
05:12AM EDT  Immuron Announced in a Publication from the Hebrew University Hadassah Medical Center 'Augmented Antiviral T Cell Immunity by Oral Administration of Imm-124e in Preclinical Models and a Phase I/iia Clinical Trial: a Method for the Prevention and Treatment of Covid-19'   Benzinga
Oct 7, 2021
08:24AM EDT  The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results   Benzinga
Oct 6, 2021
07:33AM EDT  The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal   Benzinga
Sep 30, 2021
07:43AM EDT  The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug   Benzinga
Sep 23, 2021
11:00PM EDT  Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutic products for the prevention and treatment of gut pathogens, today received the resignation of Mr Peter Anastasiou.   GlobeNewswire Inc
09:00AM EDT  Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutic products for the prevention and treatment of gut pathogens, today would like to provide shareholders and the market with an update to our market announcements of 8 June 2021 and 7 July 2021.   GlobeNewswire Inc
07:16AM EDT  Immuron Limited ADS Shares To Resume Trade At 7:20 a.m. ET; Shares Were Halted on May 27, 2021   Benzinga
07:13AM EDT  Immuron Announced Earlier it Will Not Proceed WIth Proposed Acquisition of R&D Vaccine Company   Benzinga
07:08AM EDT  Immuron Limited ADS Shares To Resume Trade At 7:20 a.m. ET   Benzinga
Aug 31, 2021
07:22AM EDT  Immuron FY21 Sales $145,776, Down From $2.52M YoY, EPS $(3.79), Down From $(1.66) YoY   Benzinga
May 27, 2021
09:26AM EDT  UPDATE: Immuron Shares Were Halted Wednesday On Australia's Stock Exchange Ahead Of A Disclosed M&A Announcement   Benzinga
09:23AM EDT  Immuron Shares Halted News Pending   Benzinga
May 13, 2021
06:15AM EDT  Immuron Says Highlights Monash University Research Update On SARS-CoV-2 program   Benzinga
06:00AM EDT  IMM124E May offer a New modality for Inhibition   GlobeNewswire Inc
Jan 11, 2021
06:00AM EST  Immuron to Participate in H.C. Wainwright & Co. BioConnect 2021   GlobeNewswire Inc
Dec 15, 2020
08:29AM EST  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Dec. 15, 2020: FDX, XPEV, CWH, IMRN, TMBR   Benzinga
06:53AM EST  Immuron PR Confirms Co. Recently Executed SARS-CoV-2 Research Services Agreement With Monash University To evaluate IMM-124E   Benzinga
06:53AM EST  Immuron Says Recently Executed SARS-CoV-2 Research Services Agreement With Monash University To evaluate IMM-124E   Benzinga
06:00AM EST  Immuron SARS-CoV-2 Research Agreement with Monash University   GlobeNewswire Inc
Nov 24, 2020
06:00AM EST  Immuron Receives AUD $358,280 R&D Tax Concession Refund   GlobeNewswire Inc
Nov 11, 2020
01:28PM EST  Yahoo Finance Trending Stocks For Wednesday, Nov. 11, 2020: FPRX, DDOG, FTEK, VXRT, RKT, PLUG, SRNE, REV, GNUS, SPCE, MYO, FUBO, MRNA, PSHG, IMRN, MAPT, LYFT, BRKS, PACB, APD, NKLA, QCOM, MOMO, OASPQ, LMND, COHR, PDD, EQ, MDGS   Benzinga
06:00AM EST  US DoD Naval Medical Research Center Reports Positive   GlobeNewswire Inc
Oct 12, 2020
06:00AM EDT  Immuron Travelers Diarrhea Market Update   GlobeNewswire Inc
Jul 23, 2020
12:45PM EDT  Immuron Limited Announces Closing of $20.0 Million Registered   GlobeNewswire Inc
Jul 21, 2020
10:13AM EDT  Mid-Morning Market Update: Markets Mostly Higher; Coca-Cola Earnings Beat Views   Benzinga
10:06AM EDT  Shares of Australia-based biopharmaceutical company Immuron Limited (IMRN) are gaining more than 81 percent or $8.49 in Tuesday's morning trade at $18.90.   RTTNews
08:48AM EDT  Immuron Announces $20M Offering; Priced $18.75/ADS   Benzinga
08:46AM EDT  Immuron Announces $20.0 Million Registered Direct Offering   GlobeNewswire Inc
07:10AM EDT  Immuron Reports IMM-124E Used To Manufacture Travelan And Protectyn Demonstrates Antiviral Activity Against The COVID-19 Virus In Laboratory Studies   Benzinga
07:00AM EDT  -- Immurons IMM-124E used to manufacture Travelan and Protectyn demonstrates antiviral activity against the COVID-19 virus in laboratory studies -- Immurons technology platform offers a potential new oral therapeutic approach to target SARS-CoV-2 in the GI Tract   GlobeNewswire Inc
06:00AM EDT  A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings   Benzinga
Jul 20, 2020
08:13PM EDT  Immuron Reports Neutralizing activity Against SARS-CoV-2   Benzinga
02:39PM EDT  Mid-Afternoon Market Update: Dow Turns Positive; Majesco Shares Climb   Benzinga
12:00PM EDT  Mid-Day Market Update: Nasdaq Rises Over 1%; Immuron Shares Spike Higher   Benzinga
10:19AM EDT  Shares of Immuron Ltd. (IMRN) more than doubled on Monday morning after the pharma company said it received U.S. Food and Drug Administration guidance for a new drug designed to treat diarrhoea.   RTTNews
10:12AM EDT  Mid-Morning Market Update: Markets Mixed; Halliburton Profit Beats Views   Benzinga
10:00AM EDT  Immuron Shares Halted On Volatility; Shares Up 130%   Benzinga
09:04AM EDT  Stock Alert: Immuron Shares Soar 76% In Early Trade   RTTNews
06:35AM EDT  Immuron to Conduct 2 Human Phase 2 Trials in 2021 Following Guidance From FDA   Benzinga
06:00AM EDT  US DoD Naval Medical Research Center Receives FDA Guidance on the   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC